Form 4 for IPSC Century Therapeutics, Inc.
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0001062993-24-006182 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-11 | 2024-03-07 | IPSC | Farid Adrienne | Chief Ops Off | A - Grant | $0.00 | +24.0K | 138.1K | +21% | $0 |
| D | 2024-03-11 | 2024-03-07 | IPSC | Farid Adrienne | Chief Ops Off | A - Grant | $0.00 | +146.0K | 146.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-07 | A | A | 24,000 | $0.00 | 138,149 | D | — | — | (F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on March 7, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. |
| 2 | Derivative | Stock Option (right to buy) | 2024-03-07 | A | A | 146,000 | $0.00 | 146,000 | D | $5.32 · — to 2034-03-07 | 146,000 Common Stock | (F2) The option vests 25% on March 7, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. |